We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder
In honor of International Plasma Awareness Week (IPAW), Eduardo Munoz, PE, CRB’s market lead for plasma-derived therapies, shares why his work in this segment is rewarding.